Taysha Gene Therapies Inc (TSHA)
1.265
-0.08
(-5.60%)
USD |
NASDAQ |
Nov 05, 14:51
Taysha Gene Therapies Profit Margin (Quarterly): -1.88K% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -1.88K% |
| March 31, 2024 | -705.4% |
| December 31, 2023 | |
| September 30, 2023 | -2.47K% |
| Date | Value |
|---|---|
| June 30, 2023 | -1.03K% |
| March 31, 2023 | -374.5% |
| December 31, 2022 | -2.20K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-2.47K%
Minimum
Sep 2023
-374.5%
Maximum
Mar 2023
-1.44K%
Average
-1.45K%
Median
Profit Margin (Quarterly) Benchmarks
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | -3.67K% |
| IGC Pharma Inc | -874.3% |
| NovaBay Pharmaceuticals Inc | -66.04% |
| Protalix BioTherapeutics Inc | -16.35% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -377.5% |
| Return on Assets | -71.15% |
| Return on Invested Capital | -164.7% |
| Operating Margin (Quarterly) | -1.92K% |
| Return on Net Operating Assets | -445.0% |